Breaking
Sunday, June 21, 2026

Drug Approvals

🇺🇸 FDA Page 50

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 589–600 of 665 articles

High impact NewsApr 17, 2026

FDA Approves RenalProtect for Diabetic Kidney Disease Treatment

FDA · Diabetic Kidney Disease · 5 min

Dr. Sarah Mitchell
High impact NewsApr 16, 2026

Mabwell's MAIWEIJIAN Denosumab Gets NMPA Acceptance for Expanded Cancer Bone Treatment

2 min

James Chen, PharmD
Critical impact NewsApr 16, 2026

Neffy Epinephrine Nasal Spray Approved in Canada as First Needle-Free Anaphylaxis Treatment by ARS Pharmaceuticals

2 min

Dr. Sarah Mitchell
Critical impact NewsApr 16, 2026

FDA Approves RAPIBLYK (Landiolol) for Pediatric Supraventricular Tachycardia - AOP Health US Expands Critical Care Treatment Options

FDA · 3 min

Dr. Sarah Mitchell
High impact NewsApr 16, 2026

FDA Approval NanoPharm Therapy: Accelerated OK for Metastatic Breast Cancer

FDA · Metastatic breast cancer · 8 min

Dr. Sarah Mitchell
High impact NewsApr 16, 2026

FDA Approves FluGuard+ Vaccine: Enhanced Protection Against Emerging Flu

FDA · Influenza · 7 min

Dr. Sarah Mitchell
High impact NewsApr 15, 2026

FDA Accepts Praxis Precision Medicines' New Drug Application for Ulixacaltamide HCl Essential Tremor Treatment

FDA · 2 min

Dr. Sarah Mitchell
Critical impact NewsApr 15, 2026

FDA Approves FILSPARI (Sparsentan) for FSGS: First Treatment for Rare Kidney Disease

FDA · Nephrology - Focal Segmental Glomerulosclerosis (FSGS) · 4 min

Dr. Sarah Mitchell
High impact NewsApr 15, 2026

Apotex Receives FDA Approval for First Generic Infuvite Adult Injection with 180-Day Exclusivity

FDA · 2 min

James Chen, PharmD
High impact NewsApr 15, 2026

FDA Approves RARE-Cure’s Orphan Drug Enzyme Replacement Therapy

FDA · Rare Metabolic Disorders · 5 min

Dr. Sarah Mitchell
High impact NewsApr 15, 2026

FDA Approves MigraEase: Faster Relief Migraine Drug Launch

FDA · Neurology · 7 min

Dr. Sarah Mitchell
High impact NewsApr 15, 2026

FDA Approves Elahere: Expanded Use for Platinum-Resistant Ovarian Cancer

FDA · Ovarian Cancer · 4 min

Dr. Sarah Mitchell